Abstract：
When the COVID-19 pandemic struck and China reported the first case to the World Health Organization in December 2019, there was no evidence-based treatment to combat it. With the catastrophic situation that followed, materialised by a considerable number of deaths, researchers, doctors, traditional healers, and governments of all nations committed themselves to find therapeutic solutions, including preventive and curative. There are effective treatments offered both by modern medicine and traditional medicine for COVID-19 today. However, other therapeutic proposals have not been approved due to the lack of effectiveness and scientific rigour during their development process. Proponents of modern medicine prefer biomedical therapies while in some countries, traditional treatments are used regularly because of their availability, affordability and satisfaction they bring to the population. In this paper, we propose a transactional medicine approach where the interaction between traditional and modern medicine produces a change. With this approach, the promoters of traditional medicine and those of modern medicine will be able to acquire knowledge through the experience produced by their encounters. Transactional medicine aims to be a model for decolonising medicine and recognising the value of both traditional and modern medicine in the fight against COVID-19 and other global emerging pathogens.
摘要：
当COVID-19大流行来袭，中国于2019年12月向世界卫生组织报告了第一例病例时，没有循证治疗来对抗它。随之而来的灾难性情况，由相当数量的死亡而成为现实，研究人员,医生,传统治疗师，所有国家的政府都承诺寻找治疗解决方案，包括预防和治疗。今天，现代医学和传统医学都为COVID-19提供了有效的治疗方法。然而,由于在开发过程中缺乏有效性和科学严谨，其他治疗方案尚未获得批准。现代医学的支持者更喜欢生物医学疗法，而在一些国家，传统的治疗方法经常使用，因为它们的可用性，他们给人们带来的负担能力和满意度。在本文中,我们提出了一种交易医学方法，传统和现代医学之间的相互作用产生了变化。通过这种方法，传统医学和现代医学的推动者将能够通过他们相遇产生的经验获得知识。交易医学旨在成为非殖民化医学的典范，并认识到传统和现代医学在对抗COVID-19和其他全球新兴病原体中的价值。
